荣昌生物(09995.HK) 今日(26日)高开0.9%,早段曾升8.6%高见96.35元。现报94.5元,升6.54%,成交381.27万股,涉资3.56亿元。
公司日前公布业绩,收益录得10.9亿人民币(下同),按年增加47.6%,主要是公司自身免疫类商业化产品泰它西普以及抗肿瘤类商业化产品维迪西妥单抗销售增长强劲;亏损由上年同期7.8亿元,收窄至4.5亿元。不派息。(ss/)(港股报价延迟最少十五分钟。沽空资料截至 2025-08-25 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.